Stealth BioTherapeutics Receives FDA Accelerated Approval for Forzinity in Barth Syndrome
CompanyDrug

Stealth BioTherapeutics Receives FDA Accelerated Approval for Forzinity in Barth Syndrome

China Drug Procurement: Centralized Rules Shape 11th Round Of VBP
Policy / Regulatory

China Drug Procurement: Centralized Rules Shape 11th Round Of VBP

Genrix Bio Secures Exclusive Deal for Vecantoxatug and Silevimig with CMS
CompanyDeals

Genrix Bio Secures Exclusive Deal for Vecantoxatug and Silevimig with CMS

Roche’s SC Lunsumio Gains CHMP Recommendation for Relapsed Follicular Lymphoma
CompanyDrug

Roche’s SC Lunsumio Gains CHMP Recommendation for Relapsed Follicular Lymphoma

Roche’s giredestrant Yields Positive PFS Results in evERA Phase III Study
CompanyDrug

Roche’s giredestrant Yields Positive PFS Results in evERA Phase III Study

Shanghai Sanyou Medical’s Agloe Robot Enters Chinese NMPA Special Review for Innovative Spine Devices
Medical Device

Shanghai Sanyou Medical’s Agloe Robot Enters Chinese NMPA Special Review for Innovative Spine Devices

Eisai Secures FDA Fast Track for Etalanetug, a Tau Antibody Targeting MTBR
CompanyDrug

Eisai Secures FDA Fast Track for Etalanetug, a Tau Antibody Targeting MTBR

Pfizer to Acquire Metsera for $4.9 B, Expanding Its Obesity & Cardiometabolic Pipeline
CompanyDeals

Pfizer to Acquire Metsera for $4.9 B, Expanding Its Obesity & Cardiometabolic Pipeline

Youcare Pharma Secures FDA Approval for YKYY013, a Novel siRNA Therapy for Chronic Hepatitis B
CompanyDrug

Youcare Pharma Secures FDA Approval for YKYY013, a Novel siRNA Therapy for Chronic Hepatitis B

National Healthcare Security Administration Announces Nationwide Pilot for Real‑World Medical‑Insurance Value Evaluation
Policy / Regulatory

National Healthcare Security Administration Announces Nationwide Pilot for Real‑World Medical‑Insurance Value Evaluation

Huadong Medicine Secures FDA IND Approval for HDM2017 ADC
CompanyDrug

Huadong Medicine Secures FDA IND Approval for HDM2017 ADC

Sichuan Kelun‑Biotech’s A400 Receives NDA Acceptance in China
CompanyDrug

Sichuan Kelun‑Biotech’s A400 Receives NDA Acceptance in China